Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05991817

Sevoflurane General Anesthetic and Spatial Memory in Humans

The goal of this observational study is to learn about the effect of general anesthetic on spatial memory in adults who will undergo to an elective surgery. The main question it aims to answer is:

• A surgical event under general anesthesia with sevoflurane transiently impairs spatial memory in humans and induces an increase in inflammatory cytokines.

Participants will perform a virtual maze test and plasma samples will be taken before and after surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

30 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile, Santiago, RM, Chile

Loading trial locations.

About this study

Postoperative cognitive dysfunction (POCD) occurs after a surgical event under general anesthesia and is characterized by a decline in one or more cognitive functions. POCD is defined as delayed neurocognitive recovery if it takes place within the first 30 days, if it exceeds that time it is known as postoperative neurocognitive disorder. The pathogenesis of this dysfunction is not entirely clear. However, the most accepted hypothesis would be neuroinflammatory, which would take place due to the contribution of inflammatory factors typical of surgical trauma under general anesthesia, with anesthetics such as sevoflurane. Consequently, one of the areas most susceptible to this inflammatory environment would be the hippocampus, a structure responsible for learning and memory. Spatial memory is responsible for encoding and retrieving information about the environment and spatial orientation. To confirm this hypothesis, an elective laparoscopic cholecystectomy under general anesthesia with sevoflurane, plasma measurement of cytokines interleukin-1beta and tumor necrosis factor-alpha and virtual navigation tests will be performed before and after an elective laparoscopic cholecystectomy under general anesthesia with sevoflurane, in order to establish a correlation between the inflammatory component and performance in the virtual navigation test. The above will allow us to elucidate the possible occurrence of a delayed neurocognitive recovery related to spatial memory in middle-aged individuals, providing new background related to an age group that has been little studied, with a non-minor incidence (30%), where the evident concern arises for being a population exposed to activities or environments of greater risk, linked to work, sport, driving, among others. This finding will guide the doctor and the patient to decide or take the necessary safeguards when proceeding with a surgical intervention in the middle-aged population.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Candidate for elective laparoscopic surgery of cholecystectomy.
  • Age 30 to 50 years.

Exclusion criteria

  • Visual or hearing difficulties.
  • Malignant hyperthermia.
  • Being treated with centrally acting drugs, such as anxiolytics, antidepressants, antipsychotics, anticonvulsants, anticholinergics, and first-generation antihistamines.
  • Present a disorder of the sphere of neuropsychiatry
  • Substance abuse disorder.

Treatment and study plan

Surgery/general anesthesia

Procedure

Adult patients between the ages of 30 and 50 who are to undergo elective surgery under general anesthesia will have their spatial memory tested and interleukin 1beta and alpha tumor necrosis measured before and after surgery.

Primary outcomes

  1. Virtual spatial memory

    Time frame: 1th day after surgery

    Time to reach the goal

Secondary outcomes

  1. Interleukin-1beta

    Time frame: 1st day after surgery

    Interleukin-1beta plasma concentration

  2. Interleukin-1beta

    Time frame: 7th day after surgery

    Interleukin-1beta plasma concentration

  3. Interleukin-1beta

    Time frame: 30th day after surgery

    Interleukin-1beta plasma concentration

  4. Tumor necrosis factor alpha

    Time frame: 1st day after surgery

    Tumor necrosis factor alpha plasma concentration

  5. Tumor necrosis factor alpha

    Time frame: 7th day after surgery

    Tumor necrosis factor alpha plasma concentration

  6. Tumor necrosis factor alpha

    Time frame: 30th day after surgery

    Tumor necrosis factor alpha plasma concentration

  7. Virtual spatial memory

    Time frame: 7st day after surgery

    Time to reach the goal

  8. Virtual spatial memory

    Time frame: 30th day after surgery

    Time to reach the goal

Study contacts

Contact information is provided by the study sponsor or research team.

Antonello Penna, MD, PhD

CONTACT

[email protected]

+56956766623

Khaleed Etchegaray

CONTACT

[email protected]

+56973310929

Sponsors and collaborators

Lead sponsor

University of Chile

Other

Registry information

Official study title

Study of the Effect of Sevoflurane General Anesthetic on Spatial Memory in Humans

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 15, 2023
Registry last updated
Nov 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.